NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
10/05/2023
Back to search
Official data from USPTO
Z
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
10/05/2023
Trademark type
Combined
Nice classes
42
Filing date
02/29/2016
Registration date
10/31/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/05/2023
Last transaction
10/05/2023
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
06/22/2015
First use in commerce
03/31/2016
Drawing code
3
Owner type
03
Owner location
Cambridge, MA, US
Examiner
FOSDICK, GEOFFREY
Law office
M20
Current location
TMO LAW OFFICE 111
Mark description
The mark consists of a orange colored shield with the letter "Z" included in the shield in white.
Holders and representatives
Holders
Zumutor Biologics Inc
Zumutor Biologics Inc
Representatives
Zumutor Biologics Inc
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Bacteriological consultation and research; Bacteriological research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemicalbiochemicalbiological and bacteriological research and analysis; Compiling data for research purposes in the field of medical science and medical consultancy; Conducting clinical trials for others in the field of oncologyrheumatoid arthritisdiabetes and metabolic disorders; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Development of pharmaceutical preparations and medicines; Diagnostic services in the field of oncologyrheumatoid arthritisdiabetes and metabolic disorders; Drug discovery services; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genotyping services for research or analysis purposes; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of oncologyrheumatoid arthritisdiabetes and metabolic disorders; Medical and scientific research information in the field of oncologyrheumatoid arthritisdiabetes and metabolic disorders; Medical and scientific researchconducting clinical trials for others; Medical research; Medical research services in the field of cancer; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of oncologyrheumatoid arthritisdiabetes and metabolic disorders; Research on the subject of pharmaceuticals; Researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research and development; Scientific research consulting in the field of oncologyrheumatoid arthritisdiabetes and metabolic disorders; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of oncologyrheumatoid arthritisdiabetes and metabolic disorders; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of oncology; Scientific study and research in the field(s) of rheumatoid arthritis; Scientific study and research in the field(s) of diabetes; Scientific study and research in the field(s) of metabolic disorders; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies
Publications
History of USPTO decisions and trademark events.
29 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
10/05/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/05/2023
ES8R
TEAS SECTION 8 RECEIVED
05/26/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/31/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/31/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/27/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/26/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/20/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/14/2017
IUAF
USE AMENDMENT FILED
08/28/2017
EISU
TEAS STATEMENT OF USE RECEIVED
08/28/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/28/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2017
PUBO
PUBLISHED FOR OPPOSITION
01/03/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/14/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/29/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/23/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/22/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/22/2016
ALIE
ASSIGNED TO LIE
11/08/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/28/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/10/2016
GNRT
NON-FINAL ACTION E-MAILED
06/10/2016
CNRT
NON-FINAL ACTION WRITTEN
06/10/2016
DOCK
ASSIGNED TO EXAMINER
06/10/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/04/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/03/2016
NWAP
NEW APPLICATION ENTERED
03/03/2016
Continuous trademark protection
Get notified about every new filing that threatens Z or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.